Cite
HARVARD Citation
Douglas, G. et al. (2023). Effective CMV prophylaxis with high‐dose valaciclovir in allogeneic hematopoietic stem‐cell recipients at a high risk of CMV infection. Transplant infectious disease. 25 (1), p. n/a. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Douglas, G. et al. (2023). Effective CMV prophylaxis with high‐dose valaciclovir in allogeneic hematopoietic stem‐cell recipients at a high risk of CMV infection. Transplant infectious disease. 25 (1), p. n/a. [Online].